Dr. Paul Huckle is Chief Regulatory Officer and Senior Vice-President of Global Regulatory Affairs and Quality Assurance at GlaxoSmithKline. He chairs the Global Regulatory Governance Board for GlaxoSmithKline. He is responsible for the filing of new submissions and support for existing licences worldwide. He also leads the global regulatory support groups (CMC, preclinical, labelling, systems and operations), as well as Quality Assurance for the worldwide R&D organisation.

Dr. Huckle sits on the Scientific Advisory Board and the Advisory Management Committee for the Centre for Innovation in Regulatory Science (CIRS), and is a member of the Advisory Board for the Duke-NUS Centre for Regulatory Excellence (CoRE). He recently served as the Designated Expert representing PhRMA on the ICH Expert Working Group for M4E(R2) (Benefit – Risk Information). He is an Honorary Life Member of TOPRA – The Organisation for Professionals in Regulatory Affairs.

Before entering the regulatory field Dr. Huckle worked for ten years in pharmaceutical development with responsibility for leading the development of both prescription and OTC products.

Prior to joining industry Dr. Huckle held a position at The School of Pharmacy, University of London. He holds a degree in Pharmacy and a Ph.D. in Pharmaceutics from the University of London and is a Member of the Royal Pharmaceutical Society of Great Britain. He holds dual citizenship; UK and USA.